More recently, Bajko et al. [128] showed that stimulation with interleukins IL-4, IL-13, or IL-17a increased pendrin levels in human bronchial epithelial cells from CF patients (CF HBECs) and non-CF donors (HBECs) [121,129]. This evidence concerns the gene IL13 and cystic fibrosis.